Furosemide and Retacrit drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Furosemide (furosemide) and Retacrit (epoetin alfa-epbx). Common drug interactions include staphylococcal infection among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Furosemide and Retacrit. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Retacrit?

Retacrit has active ingredients of epoetin alfa-epbx. eHealthMe is studying from 2,196 Retacrit users. Check the latest studies of Retacrit.



On Jul, 29, 2026

87 people who take Furosemide and Retacrit together, and have interactions are studied.

Furosemide and Retacrit drug interactions.

What are the common drug interactions of Furosemide and Retacrit, by gender? *:

female:

  1. Staphylococcal infection (an infection with staphylococcus bacteria)
  2. Stenotrophomonas infection
  3. Systemic candida (whole body fungal infection)
  4. Abdominal distension
  5. Abdominal pain upper
  6. Anal cancer recurrent
  7. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  8. Arthralgia (joint pain)
  9. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  10. Cervical dysplasia (abnormal changes in the cells on the surface of the cervix)

male:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Pneumonia
  3. Injection site pruritus (severe itching at injection site)
  4. Injection site reaction
  5. Presyncope
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Haemoglobin decreased
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Haematocrit decreased
  10. Alcoholic pancreatitis

What are the common drug interactions of Furosemide and Retacrit, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pneumonia
  2. Acidosis (build-up of carbon dioxide in the blood)
  3. Ammonia increased
  4. Anaemia (lack of blood)
  5. Blood bicarbonate decreased
  6. Blood potassium decreased
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  9. Diarrhoea
  10. Drug ineffective

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
  3. Drug hypersensitivity
  4. Injection site pain
  5. Injection site pruritus (severe itching at injection site)
  6. Injection site reaction

50-59:

  1. Hyperkalaemia (damage to or disease of the kidney)
  2. Blood disorder
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Oral herpes (viral infection of mouth)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Mucosal inflammation (infection of mucous membrane)
  7. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  8. Anaemia (lack of blood)
  9. Anxiety
  10. Back pain

60+:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Pneumonia
  3. Abdominal pain
  4. C-reactive protein increased
  5. Chills (felling of cold)
  6. Infection
  7. Presyncope
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Chest pain

What are the existing conditions these people have? *

  1. Anaemia (lack of blood): 24 people, 27.59%
  2. High Blood Pressure: 23 people, 26.44%
  3. Multiple Myeloma (cancer of the plasma cells): 15 people, 17.24%
  4. Stress And Anxiety: 13 people, 14.94%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 12 people, 13.79%
  6. Vitamin B12 Deficiency: 11 people, 12.64%
  7. Seasonal Allergy (allergic condition due to certain season): 11 people, 12.64%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 11.49%
  9. Diabetes: 9 people, 10.34%
  10. Aortic Valve Incompetence: 7 people, 8.05%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and Retacrit?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Furosemide and Retacrit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Retacrit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Furosemide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Retacrit and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on furosemide and epoetin alfa-epbx (the active ingredients of Furosemide and Retacrit, respectively), and Furosemide and Retacrit (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: